BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schindeler A, Little DG. Bisphosphonate action: Revelations and deceptions from in vitro studies. Journal of Pharmaceutical Sciences 2007;96:1872-8. [DOI: 10.1002/jps.20904] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Di Pompo G, Poli F, Mandrone M, Lorenzi B, Roncuzzi L, Baldini N, Granchi D. Comparative “in vitro” evaluation of the antiresorptive activity residing in four Ayurvedic medicinal plants. Hemidesmus indicus emerges for its potential in the treatment of bone loss diseases. Journal of Ethnopharmacology 2014;154:462-70. [DOI: 10.1016/j.jep.2014.04.033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
2 Roth A, Drescher D, Yang Y, Redmer S, Uhlig S, Arenz C. Potent and Selective Inhibition of Acid Sphingomyelinase by Bisphosphonates. Angew Chem Int Ed 2009;48:7560-3. [DOI: 10.1002/anie.200903288] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 4.7] [Reference Citation Analysis]
3 Anil S, Venkatesan J, Shim M, Chalisserry E, Kim S. Bone response to calcium phosphate coatings for dental implants. Bone Response to Dental Implant Materials. Elsevier; 2017. pp. 65-88. [DOI: 10.1016/b978-0-08-100287-2.00004-5] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
4 Li B, Ling Chau JF, Wang X, Leong WF. Bisphosphonates, specific inhibitors of osteoclast function and a class of drugs for osteoporosis therapy. J Cell Biochem 2011;112:1229-42. [DOI: 10.1002/jcb.23049] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
5 Coxon FP, Thompson K, Roelofs AJ, Ebetino FH, Rogers MJ. Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells. Bone 2008;42:848-60. [DOI: 10.1016/j.bone.2007.12.225] [Cited by in Crossref: 164] [Cited by in F6Publishing: 142] [Article Influence: 11.7] [Reference Citation Analysis]
6 Kidd L, Cowling N, Wu A, Kelly W, Forwood M. Bisphosphonate treatment delays stress fracture remodeling in the rat ulna: RISEDRONATE SLOWS STRESS FRACTURE REPAIR. J Orthop Res 2011;29:1827-33. [DOI: 10.1002/jor.21464] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
7 Ohnishi T, Ogawa Y, Suda K, Komatsu M, Harmon SM, Asukai M, Takahata M, Iwasaki N, Minami A. Molecular Targeted Therapy for the Bone Loss Secondary to Pyogenic Spondylodiscitis Using Medications for Osteoporosis: A Literature Review. Int J Mol Sci 2021;22:4453. [PMID: 33923233 DOI: 10.3390/ijms22094453] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lu T, Ma Y, Hu H, Chen Y, Zhao W, Chen T. Ethinylestradiol liposome preparation and its effects on ovariectomized rats’ osteoporosis. Drug Delivery 2011;18:468-77. [DOI: 10.3109/10717544.2011.589085] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
9 Belfrage O, Isaksson H, Tägil M. Local treatment of a bone graft by soaking in zoledronic acid inhibits bone resorption and bone formation. A bone chamber study in rats. BMC Musculoskelet Disord 2012;13:240. [PMID: 23217097 DOI: 10.1186/1471-2474-13-240] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
10 Said F, Ghoul-mazgar S, Khemiss F, El Ayeb H, Saidane D, Berdal A, Ruhin-poncet B. The Effect of Etidronate on the Periodontium of Ovariectomized Rats. Journal of Periodontology 2012;83:1063-8. [DOI: 10.1902/jop.2011.110242] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
11 Belfrage O, Flivik G, Sundberg M, Kesteris U, Tägil M. Local treatment of cancellous bone grafts with BMP-7 and zoledronate increases both the bone formation rate and bone density: a bone chamber study in rats. Acta Orthop 2011;82:228-33. [PMID: 21434769 DOI: 10.3109/17453674.2011.566138] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
12 Roth A, Drescher D, Yang Y, Redmer S, Uhlig S, Arenz C. Potente und selektive Inhibition der sauren Sphingomyelinase durch Bisphosphonate. Angew Chem 2009;121:7697-700. [DOI: 10.1002/ange.200903288] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
13 Yu SJ, Liu HC, Ling-Ling E, Wang DS, Zhu GX. Proliferation and differentiation of osteoblasts from the mandible of osteoporotic rats. Exp Biol Med (Maywood) 2012;237:395-406. [PMID: 22550338 DOI: 10.1258/ebm.2011.011217] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
14 Begkas D, Pastroudis A, Touzopoulos P, Markeas NG, Chatzopoulos ST. The Effects of Long-term Use of Nitrogen-containing Bisphosphonates on Fracture Healing. Cureus 2019;11:e4307. [PMID: 31183287 DOI: 10.7759/cureus.4307] [Reference Citation Analysis]
15 Frediani B, Cavalieri L, Cremonesi G. Clodronic acid formulations available in Europe and their use in osteoporosis: a review. Clin Drug Investig 2009;29:359-79. [PMID: 19432497 DOI: 10.2165/00044011-200929060-00001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
16 Gong L, Altman RB, Klein TE. Bisphosphonates pathway. Pharmacogenet Genomics 2011;21:50-3. [PMID: 20023594 DOI: 10.1097/FPC.0b013e328335729c] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
17 Mathavan N, Bosemark P, Isaksson H, Tägil M. Investigating the synergistic efficacy of BMP-7 and zoledronate on bone allografts using an open rat osteotomy model. Bone 2013;56:440-8. [PMID: 23845325 DOI: 10.1016/j.bone.2013.06.030] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]